Stay updated on Pilot Trial Flecainide in ARVC Patients Clinical Trial
Sign up to get notified when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.

Latest updates to the Pilot Trial Flecainide in ARVC Patients Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive changes to study details or page functionality.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a consolidated 'Locations' section listing study sites in Colorado, Maryland, New York, North Carolina, and Pennsylvania, replacing separate state location subsections; updated the page revision to v3.3.3.SummaryDifference0.6%

- Check55 days agoChange DetectedRevision from v3.3.1 to v3.3.2 appears as a metadata update on the page, with no evident changes to study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedPage revision history updated to v3.3.1 and v3.2.0 removed; this is a metadata-level update with no noticeable impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange Detected- Removed the government funding lapse notice banner from the page. The remainder of the study details and related information remain unchanged.SummaryDifference0.4%

- Check83 days agoChange DetectedNo significant changes detected to the study details; the page continues to present the study overview, design, eligibility criteria, outcomes, and locations.SummaryDifference0.4%

Stay in the know with updates to Pilot Trial Flecainide in ARVC Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.